New pill tested to stop painful swelling attacks
NCT ID NCT04618211
Summary
This study tested an oral medication called deucrictibant for quickly relieving painful swelling attacks in people with hereditary angioedema (HAE). Seventy-four participants with HAE took either the study drug or a placebo pill at home when an attack started. Researchers measured how well and how fast the drug reduced skin swelling, skin pain, and abdominal pain compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Birmingham, Alabama, 35209, United States
-
Study site
Paradise Valley, Arizona, 85253, United States
-
Study site
San Diego, California, 92122, United States
-
Study site
Santa Monica, California, 90404, United States
-
Study site
Walnut Creek, California, 94598, United States
-
Study site
Chevy Chase, Maryland, 20815, United States
-
Study site
St Louis, Missouri, 63141, United States
-
Study site
Hershey, Pennsylvania, 17033, United States
-
Study site
Sofia, Bulgaria
-
Study site
Edmonton, Alberta, Canada
-
Study site
Ottawa, Ontario, Canada
-
Study site
Toronto, Ontario, Canada
-
Study site
Montreal, Quebec, Canada
-
Study site
Québec, Quebec, Canada
-
Study site
Brno, Czechia
-
Study site
Hradec Králové, Czechia
-
Study site
Grenoble, France
-
Study site
Montpellier, France
-
Study site
Paris, France
-
Study site
Berlin, Germany
-
Study site
Dresden, Germany
-
Study site
Frankfurt, Germany
-
Study site
Mainz, Germany
-
Study site
Ulm, Germany
-
Study site
Budapest, Hungary
-
Study site
Ashkelon, Israel
-
Study site
Haifa, Israel
-
Study site
Tel Aviv, Israel
-
Study site
Monserrato, Italy
-
Study site
Naples, Italy
-
Study site
Amsterdam, Netherlands
-
Study site
Krakow, Poland
-
Study site
Barcelona, Spain
-
Study site
Madrid, Spain
-
Study site
Brighton, United Kingdom
-
Study site
London, United Kingdom
Conditions
Explore the condition pages connected to this study.